Nifty
Sensex
:
:
24870.10
81306.85
-213.65 (-0.85%)
-693.86 (-0.85%)

Pharmaceuticals & Drugs - API

Rating :
63/99

BSE: 540222 | NSE: LAURUSLABS

879.10
22-Aug-2025
  • Open
  • High
  • Low
  • Previous Close
  •  889.95
  •  895.05
  •  875.1
  •  889.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1548015
  •  1366427168.75
  •  922.5
  •  427.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 47,429.02
  • 93.21
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 49,977.89
  • 0.14%
  • 10.29

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 27.59%
  • 8.52%
  • 23.12%
  • FII
  • DII
  • Others
  • 25.7%
  • 10.54%
  • 4.53%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.07
  • 2.90
  • -2.76

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.29
  • -7.41
  • -7.90

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.20
  • -18.47
  • -23.56

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 33.06
  • 35.71
  • 91.17

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.89
  • 7.52
  • 6.17

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.60
  • 23.43
  • 25.97

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
2.98
6.65
10.71
15.49
P/E Ratio
295.00
132.20
82.08
56.75
Revenue
5002
5554
6401
7504
EBITDA
749
1055
1410
1808
Net Income
161
358
577
835
ROA
2
4
6
8
P/B Ratio
11.26
10.60
9.53
8.29
ROE
3.94
8.35
12.01
15.13
FCFF
-181
-242
111
252
FCFF Yield
-0.51
-0.68
0.31
0.71
Net Debt
2436
2549
2653
2613
BVPS
78.06
82.94
92.29
105.99

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
1,569.57
1,194.91
31.35%
1,720.30
1,439.67
19.49%
1,415.05
1,194.92
18.42%
1,223.70
1,224.45
-0.06%
Expenses
1,187.44
1,023.71
15.99%
1,299.70
1,198.18
8.47%
1,129.90
1,013.50
11.48%
1,045.37
1,036.58
0.85%
EBITDA
382.13
171.20
123.21%
420.60
241.49
74.17%
285.15
181.42
57.18%
178.33
187.87
-5.08%
EBIDTM
24.35%
14.33%
24.45%
16.77%
20.15%
15.18%
14.57%
15.34%
Other Income
10.43
2.51
315.54%
58.57
18.53
216.08%
9.42
2.43
287.65%
4.60
1.78
158.43%
Interest
51.50
49.19
4.70%
56.40
50.50
11.68%
57.80
50.82
13.73%
52.61
42.39
24.11%
Depreciation
116.84
106.06
10.16%
110.43
102.25
8.00%
106.09
98.41
7.80%
107.51
93.37
15.14%
PBT
224.22
18.46
1,114.63%
312.34
107.27
191.17%
130.68
34.62
277.47%
22.81
53.89
-57.67%
Tax
63.14
6.25
910.24%
78.47
31.95
145.60%
40.07
9.45
324.02%
5.09
14.57
-65.07%
PAT
161.08
12.21
1,219.25%
233.87
75.32
210.50%
90.61
25.17
259.99%
17.72
39.32
-54.93%
PATM
10.26%
1.02%
13.59%
5.23%
6.40%
2.11%
1.45%
3.21%
EPS
3.02
0.23
1,213.04%
4.33
1.40
209.29%
1.71
0.43
297.67%
0.37
0.69
-46.38%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
5,928.62
5,553.96
5,040.83
6,040.55
4,935.57
4,813.51
2,831.72
2,291.92
2,056.17
1,904.65
1,777.58
Net Sales Growth
17.31%
10.18%
-16.55%
22.39%
2.54%
69.99%
23.55%
11.47%
7.96%
7.15%
 
Cost Of Goods Sold
2,578.48
2,395.08
2,374.35
2,729.67
2,133.89
2,107.62
1,382.88
1,224.80
1,056.02
989.29
1,000.15
Gross Profit
3,350.14
3,158.88
2,666.48
3,310.88
2,801.68
2,705.89
1,448.84
1,067.12
1,000.15
915.36
777.43
GP Margin
56.51%
56.88%
52.90%
54.81%
56.77%
56.21%
51.16%
46.56%
48.64%
48.06%
43.74%
Total Expenditure
4,662.41
4,498.68
4,263.33
4,448.36
3,513.14
3,262.83
2,267.17
1,935.93
1,642.85
1,497.01
1,415.38
Power & Fuel Cost
-
323.40
338.15
324.10
204.47
157.75
136.77
109.37
94.21
66.27
57.95
% Of Sales
-
5.82%
6.71%
5.37%
4.14%
3.28%
4.83%
4.77%
4.58%
3.48%
3.26%
Employee Cost
-
676.44
614.85
557.43
469.55
397.04
320.77
276.33
238.14
204.73
175.46
% Of Sales
-
12.18%
12.20%
9.23%
9.51%
8.25%
11.33%
12.06%
11.58%
10.75%
9.87%
Manufacturing Exp.
-
648.97
611.80
522.90
441.18
364.78
239.50
178.96
150.78
139.47
106.97
% Of Sales
-
11.68%
12.14%
8.66%
8.94%
7.58%
8.46%
7.81%
7.33%
7.32%
6.02%
General & Admin Exp.
-
201.69
157.89
151.15
146.49
133.28
114.23
97.48
73.17
65.42
49.09
% Of Sales
-
3.63%
3.13%
2.50%
2.97%
2.77%
4.03%
4.25%
3.56%
3.43%
2.76%
Selling & Distn. Exp.
-
170.95
134.49
116.14
101.98
91.65
61.53
31.96
24.09
22.65
16.49
% Of Sales
-
3.08%
2.67%
1.92%
2.07%
1.90%
2.17%
1.39%
1.17%
1.19%
0.93%
Miscellaneous Exp.
-
82.15
31.80
46.97
15.58
10.71
11.49
17.03
6.44
9.18
16.49
% Of Sales
-
1.48%
0.63%
0.78%
0.32%
0.22%
0.41%
0.74%
0.31%
0.48%
0.52%
EBITDA
1,266.21
1,055.28
777.50
1,592.19
1,422.43
1,550.68
564.55
355.99
413.32
407.64
362.20
EBITDA Margin
21.36%
19.00%
15.42%
26.36%
28.82%
32.22%
19.94%
15.53%
20.10%
21.40%
20.38%
Other Income
83.02
75.10
26.34
6.00
15.30
23.66
5.92
16.15
29.19
33.44
4.36
Interest
218.31
216.00
182.90
165.17
102.39
68.16
89.59
88.19
79.64
99.90
111.11
Depreciation
440.87
430.09
384.58
324.08
251.49
205.07
187.27
164.19
125.45
105.98
86.41
PBT
690.05
484.29
236.36
1,108.94
1,083.85
1,301.11
293.61
119.75
237.42
235.19
169.04
Tax
186.77
129.88
68.15
312.30
251.42
317.29
38.34
25.99
69.81
43.86
34.90
Tax Rate
27.07%
26.82%
28.83%
28.16%
23.20%
24.39%
13.06%
21.70%
29.40%
18.65%
20.65%
PAT
503.28
354.39
166.49
793.37
827.72
983.58
255.27
93.76
167.61
191.33
134.14
PAT before Minority Interest
504.77
354.41
168.21
796.64
832.43
983.82
255.27
93.76
167.61
191.33
134.14
Minority Interest
1.49
-0.02
-1.72
-3.27
-4.71
-0.24
0.00
0.00
0.00
0.00
0.00
PAT Margin
8.49%
6.38%
3.30%
13.13%
16.77%
20.43%
9.01%
4.09%
8.15%
10.05%
7.55%
PAT Growth
231.06%
112.86%
-79.01%
-4.15%
-15.85%
285.31%
172.26%
-44.06%
-12.40%
42.63%
 
EPS
9.32
6.57
3.08
14.70
15.33
18.22
4.73
1.74
3.11
3.54
2.48

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
4,472.56
4,110.95
4,037.53
3,351.19
2,597.55
1,769.77
1,558.41
1,482.64
1,330.45
856.80
Share Capital
107.85
107.79
107.73
107.47
107.32
106.91
106.44
106.03
105.76
82.38
Total Reserves
4,338.66
3,981.69
3,917.72
3,234.55
2,485.31
1,658.23
1,446.60
1,370.75
1,218.84
771.47
Non-Current Liabilities
1,193.33
1,159.18
1,179.48
927.98
692.84
214.24
295.49
174.30
132.34
428.11
Secured Loans
645.58
798.23
761.42
596.34
429.16
165.02
258.71
141.66
124.56
353.61
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
106.13
Long Term Provisions
106.09
93.47
81.47
72.67
63.19
45.85
30.05
20.84
14.59
6.77
Current Liabilities
3,539.72
3,112.28
2,432.26
2,681.01
2,457.15
1,692.38
1,423.90
1,306.89
1,120.75
883.75
Trade Payables
958.49
1,051.24
710.65
876.37
1,178.69
615.63
488.31
312.33
263.10
247.61
Other Current Liabilities
779.69
610.73
640.75
839.73
367.25
261.47
244.50
231.26
199.11
141.05
Short Term Borrowings
1,715.00
1,389.29
995.77
910.72
886.12
790.51
684.21
758.52
644.17
481.42
Short Term Provisions
86.54
61.02
85.09
54.19
25.09
24.77
6.89
4.78
14.37
13.66
Total Liabilities
9,335.57
8,387.03
7,660.40
6,968.04
5,750.69
3,676.39
3,277.80
2,963.83
2,583.54
2,168.66
Net Block
4,123.22
3,890.01
3,408.62
2,652.47
2,170.62
1,726.34
1,629.07
1,480.80
1,229.93
1,021.03
Gross Block
6,284.33
5,652.20
4,794.82
3,750.20
3,027.97
2,387.71
2,105.42
1,793.75
1,418.58
1,106.33
Accumulated Depreciation
2,161.11
1,762.19
1,386.20
1,097.73
857.35
661.37
476.35
312.95
188.65
85.30
Non Current Assets
5,003.25
4,552.06
4,198.72
3,623.43
2,675.83
1,864.33
1,814.84
1,716.23
1,443.71
1,165.92
Capital Work in Progress
458.36
422.84
550.78
813.22
362.17
67.18
109.63
163.18
143.26
69.60
Non Current Investment
233.26
123.98
49.90
30.81
3.41
3.41
3.40
3.40
3.40
7.04
Long Term Loans & Adv.
163.40
83.50
160.58
84.11
108.52
40.80
25.58
29.36
25.95
29.22
Other Non Current Assets
25.01
31.73
28.84
42.82
31.11
26.60
47.16
39.50
41.17
39.03
Current Assets
4,332.32
3,834.97
3,461.68
3,344.61
3,074.86
1,812.06
1,462.96
1,247.59
1,139.82
1,002.73
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,936.54
1,845.41
1,684.81
1,760.30
1,575.45
905.22
681.94
584.78
509.05
487.09
Sundry Debtors
2,007.16
1,662.92
1,580.44
1,354.18
1,306.06
791.42
709.94
570.59
567.61
444.86
Cash & Bank
144.21
141.65
48.46
75.94
48.46
1.74
3.02
3.06
4.09
28.77
Other Current Assets
244.41
37.83
39.07
19.71
144.89
113.68
68.06
89.16
59.08
42.00
Short Term Loans & Adv.
207.06
147.16
108.90
134.48
88.39
61.91
35.22
58.63
25.01
23.86
Net Current Assets
792.60
722.69
1,029.42
663.60
617.71
119.68
39.05
-59.30
19.07
118.98
Total Assets
9,335.57
8,387.03
7,660.40
6,968.04
5,750.69
3,676.39
3,277.80
2,963.82
2,583.53
2,168.65

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
601.65
665.69
993.90
911.10
733.00
347.42
297.66
342.49
331.99
181.97
PBT
484.29
236.36
1,108.94
1,083.85
1,301.11
293.61
119.75
237.42
235.19
169.04
Adjustment
629.50
562.92
485.71
351.13
254.45
293.21
247.69
216.47
199.38
200.57
Changes in Working Capital
-374.60
-29.02
-315.26
-341.61
-594.06
-199.76
-44.46
-49.48
-52.45
-154.37
Cash after chg. in Working capital
739.19
770.26
1,279.39
1,093.37
961.50
387.06
322.99
404.41
382.12
215.23
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-137.54
-104.57
-285.49
-182.27
-228.50
-39.64
-25.32
-61.91
-50.13
-33.26
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-681.72
-822.42
-996.06
-914.34
-940.99
-221.13
-252.88
-384.15
-288.67
-312.20
Net Fixed Assets
-360.50
-288.19
-567.41
-1,025.56
-572.84
-236.25
-254.84
-394.43
-354.15
-76.75
Net Investments
-105.35
-250.75
-22.40
-42.83
-260.57
-0.01
-6.57
-1.22
-24.40
-7.01
Others
-215.87
-283.48
-406.25
154.05
-107.58
15.13
8.53
11.50
89.88
-228.44
Cash from Financing Activity
39.28
249.83
-26.64
30.26
254.70
-127.66
-44.77
42.24
-53.61
103.32
Net Cash Inflow / Outflow
-40.79
93.10
-28.80
27.02
46.71
-1.37
0.02
0.59
-10.30
-26.91
Opening Cash & Equivalents
138.94
45.67
75.35
48.46
1.69
2.97
3.00
2.42
12.81
39.53
Closing Cash & Equivalent
99.54
138.94
45.67
75.35
48.46
1.69
2.97
3.00
2.42
12.81

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
82.46
75.88
74.73
62.19
48.32
33.02
29.18
27.86
25.05
99.86
ROA
4.00%
2.10%
10.89%
13.09%
20.87%
7.34%
3.00%
6.04%
8.05%
6.61%
ROE
8.30%
4.15%
21.63%
28.05%
45.15%
15.39%
6.19%
11.97%
18.12%
18.65%
ROCE
10.16%
6.64%
22.97%
25.97%
39.82%
14.14%
8.22%
13.68%
16.52%
16.35%
Fixed Asset Turnover
0.93
0.97
1.41
1.46
1.78
1.26
1.18
1.29
1.53
1.73
Receivable days
120.60
117.42
88.66
98.37
79.52
96.76
101.97
100.40
95.66
73.56
Inventory Days
124.27
127.81
104.09
123.34
94.05
102.29
100.87
96.48
94.12
97.00
Payable days
153.14
135.42
106.10
175.76
155.37
145.69
72.80
61.13
59.14
58.52
Cash Conversion Cycle
91.73
109.81
86.64
45.95
18.21
53.36
130.03
135.75
130.64
112.05
Total Debt/Equity
0.61
0.61
0.49
0.52
0.56
0.60
0.67
0.66
0.64
1.20
Interest Cover
3.24
2.29
7.71
11.59
20.09
4.28
2.36
3.98
3.35
2.52

News Update:


  • Laurus Labs receives 531.77 acres of land from Government of Andhra Pradesh
    28th Jul 2025, 12:37 PM

    The company has projected Rs 5,630 crore of investment and to provide employment to 6,350 people in three phases over a period of eight years

    Read More
  • Laurus Labs - Quarterly Results
    25th Jul 2025, 15:06 PM

    Read More
  • Laurus Labs invests Rs 39.99 crore in Laurus Bio
    26th Jun 2025, 15:08 PM

    The company has acquired Series A2 Compulsorily Convertible Preference Shares of Laurus Bio at face value of Rs 100 and premium of Rs 25,850.02

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.